Skip to search formSkip to main contentSkip to account menu

cadralazine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SummaryThe metabolism of cadralazine I was studied after oral administration to rat. Besides consistent amount of unchanged drug… 
2004
2004
SummaryCadralazine (ISF 2469) was administered to 24 hypertensive patients in single oral doses of 7.5, 10, 15, 20 and 30 mg… 
2004
2004
SummaryThe antihypertensive efficacy of a new long-lasting vasodilator, cadralazine, and the diuretic chlorthalidone have been… 
2004
2004
A rare but severe side-effect of hydralazine therapy is a syndrome similar to systemic lupus (SLE). Cadralazine is a new… 
2004
2004
SummaryThe antihypertensive effects of the hydralazine-related compound cadralazine (2-{3-[6-(2-hydroxypropyl)ethylamino… 
1997
1997
This study compared the effects of 1 year of monotherapy with a calcium-channel antagonist (nilvadipine; NIL), an angiotensin… 
1985
1985
The antihypertensive activity of a new arterial dilator, cadralazine, was evaluated in 40 patients with mild-to-moderate arterial… 
1984
1984
Hemodynamic activity of cadralazine (ethyl-2-[6-(2-hydroxypropyl)-ethylaminol-3-pyridazinyl hydrazine carboxylate), a new, long… 
1984
1984
The degradation of cadralazine in aqueous solution was investigated in relation to pH, concentration, and temperature, under… 
1983
1983
The antihypertensive activity of a new vasodilating agent (ISF 2469) cadralazine (CD) was compared in a randomized, crossover…